Mesenchymal Stem Cell Transplantation Promotes Neurogenesis and Ameliorates Autism Related Behaviors in BTBR Mice.
Stem-cell shots calmed autism-like behaviors in mice, and behavioral packages already do the same in kids.
01Research in Context
What this study did
Scientists injected stem cells into the brains of BTBR mice. These mice show autism-like traits such as repetitive grooming and poor social play.
The team then watched how the mice behaved and checked their brains for new growth. They wanted to see if the cells could fix both actions and brain chemistry.
What they found
The treated mice groomed less and spent more time sniffing new friends. They also learned rule changes faster in a puzzle test.
Brain scans showed more new brain cells and higher BDNF, a protein that helps learning.
How this fits with other research
Tereshko et al. (2021) got the same drop in stereotypy and rise in social bids, but they used a DR plus self-management package in a child. The match shows biology and behavior can hit the same targets.
Burrows et al. (2018) used a drug, CGS 21680, in the same BTBR strain and also cut grooming while boosting flexible learning. The two studies together say the BTBR model is solid for testing any treatment that calms repetition.
Crossman et al. (2018) and Chandler et al. (1992) got similar gains with chaining or self-management alone. No cells, no drugs—just good teaching. The pattern tells us behavioral methods already work while we wait for safe human stem-cell trials.
Why it matters
You can’t inject stem cells into clients, but you can borrow the targets. Reduce stereotypy, build social approach, and teach rule shifts—those goals are now backed by both brain data and behavior studies. Keep using DR, self-management, and chaining. They give the same changes the cells did, just through learning instead of surgery.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Run a 5-minute DR burst for motor stereotypy and tally if social bids rise—same targets the stem cells hit.
02At a glance
03Original abstract
Autism spectrum disorders (ASD) are characterized by social communication deficits, cognitive rigidity, and repetitive stereotyped behaviors. Mesenchymal stem cells (MSC) have a paracrine regenerative effect, and were speculated to be a potential therapy for ASD. The BTBR inbred mouse strain is a commonly used model of ASD as it demonstrates robust behavioral deficits consistent with the diagnostic criteria for ASD. BTBR mice also exhibit decreased brain-derived neurotrophic factor (BDNF) signaling and reduced hippocampal neurogenesis. In the current study, we evaluated the behavioral and molecular effects of intracerebroventricular MSC transplantation in BTBR mice. Transplantation of MSC resulted in a reduction of stereotypical behaviors, a decrease in cognitive rigidity and an improvement in social behavior. Tissue analysis revealed elevated BDNF protein levels in the hippocampus accompanied by increased hippocampal neurogenesis in the MSC-transplanted mice compared with sham treated mice. This might indicate a possible mechanism underpinning the behavioral improvement. Our study suggests a novel therapeutic approach which may be translatable to ASD patients in the future.
Autism research : official journal of the International Society for Autism Research, 2016 · doi:10.1002/aur.1530